-
23andMe Gets $300 Million Boost From GlaxoSmithKline To Develop New Drugs
Forbes | GlaxoSmithKline, a London-based drug giant is partnering with 23andMe, the San Francisco genetics startup, to develop new medicines. The companies will split costs and profits equally, and Glaxo will make a $300 million investment in 23andMe. The collaboration will last four years.
Jul 25, 2018
-
Looking Forward: How Data Science Shapes Future Work
Bio-IT World | At the 2018 Bio-IT World Conference & Expo, we dedicated a plenary session to a panel discussion on data science. Wanting to offer the conversation to our community, we asked Gaurav Kaushik, Associate Director, Data Products & Strategy at Foundation Medicine for his definition of “data science.”
Jul 25, 2018
-
Illumina Releases Open Source AI Software
Bio-IT World Brief | Illumina announced the release of open source, novel artificial intelligence (AI) software that can distinguish between potential disease-causing mutations, and the millions of benign genetic variants in individuals.
Jul 24, 2018
-
Eight New Mouse Models For Alzheimer’s Disease Available To Researchers
Bio-IT World Brief | The MODEL-AD Center, an ambitious project to develop and distribute precise mouse models of late-onset Alzheimer’s disease (AD), has released eight new models carrying genetic mutations found in patients.
Jul 23, 2018
-
Human Longevity Blasts Craig Venter, Claiming He Was Fired, Then Stole Trade Secrets — Poaching Staffers For Rival Operation
Endpoints News | On Friday, Human Longevity filed suit against ex-CEO and executive chairman Craig Venter, claiming that Venter had stolen trade secrets, recruited staffers, and planned to set up a rival organization.
Jul 23, 2018
-
VA, IBM Extend Watson For Genomics Partnership
Bio-IT World Brief | Today the US Department of Veterans Affairs and IBM Watson Health announced the extension of a public-private partnership to apply artificial intelligence to help interpret cancer data in the treatment of Veteran patients.
Jul 19, 2018
-
Quartzy Opens Second Distribution Warehouse, Expanding Options To Serve Software Customers
Bio-IT World | Quartzy, a free online laboratory supply management and ordering platform, has expanded distribution operations with a new 40,000 square foot warehouse in Hayward, California, and grown its lab supply portfolio to over three million SKUs.
Jul 19, 2018
-
Tetraphase Selects SHYFT To Support Data And Analytics For Commercial Launch Readiness
Bio-IT World Brief | SHYFT Analytics announced Tetraphase has selected its platform to support the anticipated commercial launch of eravacycline, its lead antibiotic candidate developed to address multidrug-resistant bacteria.
Jul 18, 2018
